Lakewood, Colorado, January 9, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2020, to shareholders of record at the close of business…
DetailsLakewood, Colorado, November 6, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted operating income (“AOI”) for the three months ended September 30, 2019. Financial Highlights In comparison to the same quarter in the prior year, second quarter revenues increased 3% to $25.5M,…
DetailsLakewood, Colorado, October 31, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and…
Details